AHL
NVAX icon

Abel Hall LLC’s Novavax NVAX Stock Holding History

Abel Hall LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Sell
17,593
-457
-3% -$4.09K 0.03% 773
2026
Q1 		$147K Buy
18,050
+4,241
+31% +$38.4K 0.03% 655
2025
Q4 		$92.8K Buy
+13,809
New +$104K 0.02% 615

Other funds holding NVAX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Abel Hall LLC's NVAX Position: Q2 2026 in Review

Abel Hall LLC reduced its Novavax (NVAX) stake by 2.5% in Q2 2026, selling an estimated $4.09K and leaving 17,593 shares worth $166K. The position accounts for 0.03% of the portfolio, ranked #773.

Abel Hall LLC first reported a position in NVAX in Q4 2025 and has held it in 3 quarters since. 56 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Abel Hall LLC held 17,593 shares of Novavax worth $166K as of Q2 2026.
  • Abel Hall LLC sold 457 Novavax shares in Q2 2026, an estimated $4.09K.
  • Novavax made up 0.03% of Abel Hall LLC's portfolio in Q2 2026, its #773 holding.
  • Abel Hall LLC first reported a position in Novavax in Q4 2025 and has held it in 3 quarters since.
  • 56 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.